[Immunobiological aspects of the typhoid bacteria carrier state (a review of the literature)].
D000017:ABO Blood-Group System / Q000276:immunology; D000367:Age Factors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000937:Antigen-Antibody Reactions; D000942:Antigens, Bacterial; D001789:Blood Group Antigens; D002353:Carrier State / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology; D002908:Chronic Disease; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007075:Immunoglobulin M; D007165:Immunosuppression Therapy; D007519:Isoantigens; D007740:L Forms / Q000166:cytology / Q000187:drug effects; D007962:Leukocytes / Q000276:immunology; D051379:Mice; D012485:Salmonella typhi / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D012486:Salmonella typhimurium / Q000276:immunology; D014435:Typhoid Fever / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D014436:Typhoid-Paratyphoid Vaccines / Q000627:therapeutic use
D000017:ABO Blood-Group System; D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D001789:Blood Group Antigens; D007075:Immunoglobulin M; D007519:Isoantigens; D014436:Typhoid-Paratyphoid Vaccines
Immunobiologicheskie aspekty nositel'stva briusnotifoznykh bakteriĭ (obzor literatury).